Editas Medicine (EDIT)
(Delayed Data from NSDQ)
$7.42 USD
-0.02 (-0.27%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $7.45 +0.03 (0.40%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/03/2024
Time: -- |
3/2024 | $-0.65 | -0.78% |
Earnings Summary
For their last quarter, Editas Medicine (EDIT) reported earnings of -$0.23 per share, beating the Zacks Consensus Estimate of $-0.52 per share. This reflects a positive earnings surprise of 55.77%. Look out for EDIT's next earnings release expected on May 03, 2024. For the next earning release, we expect the company to report earnings of -$0.65 per share, reflecting a year-over-year increase of 8.45%.
Earnings History
Price & Consensus
Zacks News for EDIT
Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates
EDIT: What are Zacks experts saying now?
Zacks Private Portfolio Services